When cholestasis occurs, FXR upregulates the expression of small heterodimer partner (SHP), leading to transcriptional repression of bile acid synthesis and hepatocyte BA intake, while enhancing the expression of BA export [23,25]. The gene discussed is NR0B2; the disease is cholestasis.